Phillip Monk
Chief Tech/Sci/R&D Officer at SYNAIRGEN PLC
Net worth: 37 298 $ as of 2024-05-30
Phillip Monk active positions
| Companies | Position | Start | End |
|---|---|---|---|
| SYNAIRGEN PLC | Director/Board Member | 2009-09-02 | - |
| Chief Tech/Sci/R&D Officer | 2009-09-02 | - | |
| Corporate Officer/Principal | 2006-09-30 | 2009-09-02 | |
Synairgen Research Ltd.
 Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Director/Board Member | 2009-09-02 | - |
Career history of Phillip Monk
Former positions of Phillip Monk
| Companies | Position | Start | End |
|---|---|---|---|
MedImmune Ltd.
 MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
Statistics
International
| United Kingdom | 4 |
Operational
| Director/Board Member | 2 |
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 3 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| SYNAIRGEN PLC | Health Technology |
| Private companies | 2 |
|---|---|
MedImmune Ltd.
MedImmune Ltd. BiotechnologyHealth Technology MedImmune Ltd. engages in research, development and exploitation of products in the field of molecular engineering. The company was founded on December 11, 1989 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Synairgen Research Ltd.
Synairgen Research Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Synairgen Plc, Synairgen Research Ltd. is a British company that engages in respiratory biology and develops novel therapies. The company is based in Southampton, UK. Synairgen Research was founded in 2003. | Commercial Services |
- Stock Market
- Insiders
- Phillip Monk
- Experience
